BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:45 PM
 | 
Jun 26, 2009
 |  BC Extra  |  Top Story

EASD warns of possible Lantus cancer risk

The European Association for the Study of Diabetes warned of a possible link between the use of Lantus insulin glargine from sanofi-aventis Group (Euronext:SAN; NYSE:SNY) and an increased risk of cancer, citing evidence from studies reported in the group's journal, Diabetologia. EASD said concerns about the possible link were raised by a retrospective analysis of data from...

Read the full 276 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >